Sintx Technologies (SINT) Net Income Growth (5y) (2018 - 2026)
Sintx Technologies (SINT) Net Income Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn |
| 10 | Sintx Technologies | 5.70 Mn | 3.81 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.39% |
| Dec 31, 2025 | -5.04% |
| Sep 30, 2025 | -7.74% |
| Jun 30, 2025 | 10.46% |
| Mar 31, 2025 | -31.69% |
| Dec 31, 2024 | -11.31% |
| Sep 30, 2024 | -33.96% |
| Jun 30, 2024 | -24.73% |
| Mar 31, 2024 | 11.47% |
| Sep 30, 2023 | -62.68% |
| Jun 30, 2023 | -79.70% |
| Mar 31, 2023 | -39.95% |
| Dec 31, 2022 | -57.85% |
| Sep 30, 2022 | -36.16% |
| Jun 30, 2022 | -8.08% |
| Mar 31, 2022 | -40.92% |
| Dec 31, 2021 | -13.68% |
| Sep 30, 2021 | 14.70% |
| Jun 30, 2021 | 15.37% |
| Mar 31, 2021 | 4.92% |